Global Vaccines Market Analysis 2016 - Forecast to 2022

  • ID: 3845837
  • Report
  • Region: Global
  • 132 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Vaccines Market". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Vaccines Market by Route of Type
5.1 Introduction
5.2 Multivalent Vaccines
5.3 Monovalent Vaccines

6 Vaccines Market by Product
6.1 Introduction
6.2 Recombinant Vaccines
6.3 Inactivated Vaccines
6.4 Live Attenuated Vaccines
6.5 DNA Vaccines
6.6 Toxoid Vaccines
6.7 Conjugate Vaccines
6.8 Subunit Vaccines

7 Vaccines Market by Disease Indication
7.1 Introduction
7.2 Cancer
7.3 Tuberclosis
7.4 Human Papilloma Virus (HPV) infection
7.5 Measles, Mumps & Rubella (MMR)
7.6 Pneumococcal Disease
7.7 Infectious Diseases
7.8 Hepatitis B
7.9 Typhoid
7.10 Yellow Fever
7.11 Polio
7.12 Meningococcal Disease
7.13 Influenza
7.14 Japanese Encephalitis
7.15 West Nile
7.16 Varicella
7.17 Autism
7.18 Rotavirus
7.19 DTP
7.20 Allergy
7.21 Rabies
7.22 Malaria
7.23 HIV

8 Vaccines Market by End User
8.1 Introduction
8.2 Adults
8.3 Pediatrics

9 Geographical Segmentation
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 RoW
9.4.1 Latin America
9.4.2 Middle East
9.4.3 Africa
9.4.4 Others

10 Vendor Landscaping
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Business Overview
11.1.2 SWOT Analysis
11.1.3 Financial Overview
11.1.4 Strategy
11.1.5 Key Activities
11.2 NOVARTIS AG
11.3 Glaxosmithkline, PLC.
11.4 Serum Institute of India
11.5 Johnson & Johnson
11.6 Pfizer, Inc.
11.7 Mitsubishi Tanabe
11.8 Merck & Co., Inc.
11.9 AstraZeneca
11.10 Astellas Pharma Inc.
11.11 Emergent Biosolutions, Inc.
11.12 Takeda Pharmaceuticals
11.13 Boehringer Ingelheim
11.14 Bavarian Nordic
11.15 Zoetis, Inc.
11.16 CSL Ltd

12 Appendix
13 Disclaimer

List of Tables
Table 1 Global Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Vaccines Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 3 Global Multivalent Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Multivalent Vaccines Market Analysis, by Product, 2013-2022 ($MN)
Table 5 Global Multivalent Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 6 Global Multivalent Vaccines Market Analysis, by End Userr, 2013-2022 ($MN)
Table 7 Global Monovalent Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Monovalent Vaccines Market Analysis, by Product, 2013-2022 ($MN)
Table 9 Global Monovalent Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 10 Global Monovalent Vaccines Market Analysis, by End Userr, 2013-2022 ($MN)
Table 11 Global Vaccines Market Analysis, by Product, 2013-2022 ($MN)
Table 12 Global Recombinant Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 13 Global Recombinant Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 14 Global Recombinant Vaccines Market Analysis, by End Userr, 2013-2022 ($MN)
Table 15 Global Recombinant Vaccines Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 16 Global Inactivated Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 17 Global Inactivated Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 18 Global Inactivated Vaccines Market Analysis, by End User, 2013-2022 ($MN)
Table 19 Global Inactivated Vaccines Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 20 Global Live Attenuated Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 21 Global Live Attenuated Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 22 Global Live Attenuated Vaccines Market Analysis, by End User, 2013-2022 ($MN)
Table 23 Global Live Attenuated Vaccines Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 24 Global DNA Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 25 Global DNA Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 26 Global DNA Vaccines Market Analysis, by End User, 2013-2022 ($MN)
Table 27 Global DNA Vaccines Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 28 Global Toxoid Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 29 Global Toxoid Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 30 Global Toxoid Vaccines Market Analysis, by End User, 2013-2022 ($MN)
Table 31 Global Toxoid Vaccines Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 32 Global Conjugate Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 33 Global Conjugate Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 34 Global Conjugate Vaccines Market Analysis, by End User, 2013-2022 ($MN)
Table 35 Global Conjugate Vaccines Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 36 Global Subunit Vaccines Market Analysis, by Region, 2013-2022 ($MN)
Table 37 Global Subunit Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 38 Global Subunit Vaccines Market Analysis, by End User, 2013-2022 ($MN)
Table 39 Global Subunit Vaccines Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 40 Global Vaccines Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 41 Global Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 42 Global Cancer Market Analysis, by End User, 2013-2022 ($MN)
Table 43 Global Cancer Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 44 Global Cancer Market Analysis, by Product, 2013-2022 ($MN)
Table 45 Global Tuberclosis Market Analysis, by Region, 2013-2022 ($MN)
Table 46 Global Tuberclosis Market Analysis, by End User, 2013-2022 ($MN)
Table 47 Global Tuberclosis Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 48 Global Tuberclosis Market Analysis, by Product, 2013-2022 ($MN)
Table 49 Global Human Papilloma Virus (HPV) infection Market Analysis, by Region, 2013-2022 ($MN)
Table 50 Global Human Papilloma Virus (HPV) infection Market Analysis, by End User, 2013-2022 ($MN)
Table 51 Global Human Papilloma Virus (HPV) infection Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 52 Global Human Papilloma Virus (HPV) infection Market Analysis, by Product, 2013-2022 ($MN)
Table 53 Global Measles, Mumps & Rubella (MMR) Market Analysis, by Region, 2013-2022 ($MN)
Table 54 Global Measles, Mumps & Rubella (MMR) Market Analysis, by End User, 2013-2022 ($MN)
Table 55 Global Measles, Mumps & Rubella (MMR) Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 56 Global Measles, Mumps & Rubella (MMR) Market Analysis, by Product, 2013-2022 ($MN)
Table 57 Global Pneumococcal Disease Market Analysis, by Region, 2013-2022 ($MN)
Table 58 Global Pneumococcal Disease Market Analysis, by End User, 2013-2022 ($MN)
Table 59 Global Pneumococcal Disease Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 60 Global Pneumococcal Disease Market Analysis, by Product, 2013-2022 ($MN)
Table 61 Global Infectious Diseases Market Analysis, by Region, 2013-2022 ($MN)
Table 62 Global Infectious Diseases Market Analysis, by End User, 2013-2022 ($MN)
Table 63 Global Infectious Diseases Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 64 Global Infectious Diseases Market Analysis, by Product, 2013-2022 ($MN)
Table 65 Global Hepatitis B Market Analysis, by Region, 2013-2022 ($MN)
Table 66 Global Hepatitis B Market Analysis, by End User, 2013-2022 ($MN)
Table 67 Global Hepatitis B Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 68 Global Hepatitis B Market Analysis, by Product, 2013-2022 ($MN)
Table 69 Global Typhoid Market Analysis, by Region, 2013-2022 ($MN)
Table 70 Global Typhoid Market Analysis, by End User, 2013-2022 ($MN)
Table 71 Global Typhoid Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 72 Global Typhoid Market Analysis, by Product, 2013-2022 ($MN)
Table 73 Global Yellow Fever Market Analysis, by Region, 2013-2022 ($MN)
Table 74 Global Yellow Fever Market Analysis, by End User, 2013-2022 ($MN)
Table 75 Global Yellow Fever Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 76 Global Yellow Fever Market Analysis, by Product, 2013-2022 ($MN)
Table 77 Global Polio Market Analysis, by Region, 2013-2022 ($MN)
Table 78 Global Polio Market Analysis, by End User, 2013-2022 ($MN)
Table 79 Global Polio Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 80 Global Polio Market Analysis, by Product, 2013-2022 ($MN)
Table 81 Global Meningococcal Disease Market Analysis, by Region, 2013-2022 ($MN)
Table 82 Global Meningococcal Disease Market Analysis, by End User, 2013-2022 ($MN)
Table 83 Global Meningococcal Disease Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 84 Global Meningococcal Disease Market Analysis, by Product, 2013-2022 ($MN)
Table 85 Global Influenza Market Analysis, by Region, 2013-2022 ($MN)
Table 86 Global Influenza Market Analysis, by End User, 2013-2022 ($MN)
Table 87 Global Influenza Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 88 Global Influenza Market Analysis, by Product, 2013-2022 ($MN)
Table 89 Global Japanese Encephalitis Market Analysis, by Region, 2013-2022 ($MN)
Table 90 Global Japanese Encephalitis Market Analysis, by End User, 2013-2022 ($MN)
Table 91 Global Japanese Encephalitis Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 92 Global Japanese Encephalitis Market Analysis, by Product, 2013-2022 ($MN)
Table 93 Global West Nile Market Analysis, by Region, 2013-2022 ($MN)
Table 94 Global West Nile Market Analysis, by End User, 2013-2022 ($MN)
Table 95 Global West Nile Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 96 Global West Nile Market Analysis, by Product, 2013-2022 ($MN)
Table 97 Global Varicella Market Analysis, by Region, 2013-2022 ($MN)
Table 98 Global Varicella Market Analysis, by End User, 2013-2022 ($MN)
Table 99 Global Varicella Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 100 Global Varicella Market Analysis, by Product, 2013-2022 ($MN)
Table 101 Global Autism Market Analysis, by Region, 2013-2022 ($MN)
Table 102 Global Autism Market Analysis, by End User, 2013-2022 ($MN)
Table 103 Global Autism Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 104 Global Autism Market Analysis, by Product, 2013-2022 ($MN)
Table 105 Global Rotavirus Market Analysis, by Region, 2013-2022 ($MN)
Table 106 Global Rotavirus Market Analysis, by End User, 2013-2022 ($MN)
Table 107 Global Rotavirus Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 108 Global Rotavirus Market Analysis, by Product, 2013-2022 ($MN)
Table 109 Global DTP Market Analysis, by Region, 2013-2022 ($MN)
Table 110 Global DTP Market Analysis, by End User, 2013-2022 ($MN)
Table 111 Global DTP Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 112 Global DTP Market Analysis, by Product, 2013-2022 ($MN)
Table 113 Global Allergy Market Analysis, by Region, 2013-2022 ($MN)
Table 114 Global Allergy Market Analysis, by End User, 2013-2022 ($MN)
Table 115 Global Allergy Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 116 Global Allergy Market Analysis, by Product, 2013-2022 ($MN)
Table 117 Global Rabies Market Analysis, by Region, 2013-2022 ($MN)
Table 118 Global Rabies Market Analysis, by End User, 2013-2022 ($MN)
Table 119 Global Rabies Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 120 Global Rabies Market Analysis, by Product, 2013-2022 ($MN)
Table 121 Global Malaria Market Analysis, by Region, 2013-2022 ($MN)
Table 122 Global Malaria Market Analysis, by End User, 2013-2022 ($MN)
Table 123 Global Malaria Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 124 Global Malaria Market Analysis, by Product, 2013-2022 ($MN)
Table 125 Global HIV Market Analysis, by Region, 2013-2022 ($MN)
Table 126 Global HIV Market Analysis, by End User, 2013-2022 ($MN)
Table 127 Global HIV Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 128 Global HIV Market Analysis, by Product, 2013-2022 ($MN)
Table 129 Global Vaccines Market Analysis, by End User, 2013-2022 ($MN)
Table 130 Global Audlts Market Analysis, by Region, 2013-2022 ($MN)
Table 131 Global Audlts Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 132 Global Audlts Market Analysis, by Product, 2013-2022 ($MN)
Table 133 Global Audlts Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 134 Global Pediatrics Market Analysis, by Region, 2013-2022 ($MN)
Table 135 Global Pediatrics Market Analysis, by Route of Type, 2013-2022 ($MN)
Table 136 Global Pediatrics Market Analysis, by Product, 2013-2022 ($MN)
Table 137 Global Pediatrics Market Analysis, by Disease Indication, 2013-2022 ($MN)

Note: Regional tables are presented in the similar manner as the above
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll